Abstract
Potassium chloride (KCl) supplementation is common among critically ill children. Intravenous (IV) KCl supplementation for pediatric patients is poorly characterized. This study aimed to examine the efficacy and safety of IV KCL and to determine factors affecting patient responses to IV KCL in the pediatric cardiac intensive care unit (CICU). A retrospective review of 211 children (794 KCl doses) undergoing cardiac surgery or a hospital stay for heart failure in the CICU of a tertiary care teaching and referral children’s hospital in 2011 was performed. Demographic data, weight, height, creatinine, and concomitant medications during each KCl dose were recorded and analyzed. Body surface area (BSA), creatinine clearance, and change in [K+] were calculated. The median age of the children was 4 months (range, 10 days–18 years). In this study, 151 KCl doses were administered to neonates (19 %), 307 doses (39 %) to females, and 510 doses (64 %) to patients with a BSA smaller than 0.33 m2 (a group with relative renal insufficiency). The mean KCl dose was 0.97 ± 0.006 mEq/kg. No adverse events were associated with IV KCl administration. Blood/plasma [K+] increased 0.8 ± 0.02 mEq/L. The responses to KCl did not differ significantly between males and females, between neonates and children, or between patients with a BSA smaller than 0.33 m2 and those with a BSA of 0.33 m2 or larger. The responses to IV KCl were attenuated by concomitant furosemide (p = 0.01), amphotericin B (p < 0.01), and KCl in parenteral nutrition (p < 0.01). The responses were augmented by concomitant enalapril (p = 0.03), ethacrynic acid (p < 0.001), and hemodialysis (p < 0.01). Intravenous KCl can be administered safely for CICU patients. Responses to KCl are altered when it is given with certain medications. Intravenous KCl should be used cautiously in children receiving angiotensin-converting enzyme inhibitors. Future studies are needed for further characterization of factors affecting responses to IV KCl in children.
Similar content being viewed by others
References
Charleson HA, Bailey RR, Stewart A (1980) Quick prediction of creatinine clearance without the necessity of urine collection. N Z Med J 92:425–426
Franke HA, Woods DM, Holl JL (2009) High-alert medications in the pediatric intensive care unit. Pediatr Crit Care Med 10:85–90
Haycock GB, Schwartz GJ, Wisotsky DH (1978) Geometric method for measuring body surface area: a height-weight formula validated in infants, children, and adults. J Pediatr 93:62–66
Johnson RG, Shafique T, Sirois C, Weintraub RM, Comunale ME (1999) Potassium concentrations and ventricular ectopy: a prospective, observational study in postcardiac surgery patients. Crit Care Med 27:2430–2434
Kruse JA, Carlson RW (1990) Rapid correction of hypokalemia using concentrated intravenous potassium chloride infusions. Arch Intern Med 150:613–617
Kruse JA, Clark VL, Carlson RW, Geheb MA (1994) Concentrated potassium chloride infusions in critically ill patients with hypokalemia. J Clin Pharmacol 34:1077–1082
Lopez R, Lema G, Gonzalez A et al (2012) Plasma levels of potassium and magnessium after modified ultrafiltration in pediatric cardiac surgery with cardiopulmonary bypass. Perfusion 27:40–42
Moffett BS, McDade E, Rossano JW, Dickerson HA, Nelson DP (2011) Enteral potassium supplementation in a pediatric cardiac intensive care unit: evaluation of a practice change. Pediatr Crit Care Med 12:552–554
Polderman KH, Girbes AR (2004) Severe electrolyte disorders following cardiac surgery: a prospective controlled observational study. Crit Care 8:R459–R466
Rex JH, Turnbull JE, Allen SJ, Vande Voorde K, Luther K (2000) Systematic root cause analysis of adverse drug events in a tertiary referral hospital. Jt Comm J Qual Improv 26:563–575
Schaber DE, Uden DL, Stone FM, Singh A, Katkov H, Bessinger FB (1985) Intravenous KCl supplementation in pediatric cardiac surgical patients. Pediatr Cardiol 6:25–28
Schwartz GJ, Haycock GB, Edelmann CM Jr, Spitzer A (1976) A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 58:259–263
Sharkey I, Boddy AV, Wallace H, Mycroft J, Hollis R, Picton S (2001) Body surface area estimation in children using weight alone: application in paediatric oncology. Br J Cancer 85:23–28
Singhi S, Marudkar A (1996) Hypokalemia in a pediatric intensive care unit. Indian Pediatr 33:9–14
Singhi S, Gautham KS, Lal A (1994) Safety and efficacy of a concentrated potassium chloride solution infusion for rapid correction of hypokalemia. Indian Pediatr 31:565–569
Sladdin C, Lee G (2006) Safely treating hypokalaemia in high-dependency cardiac surgical patients. Nurs Crit Care 11:267–272
White JR, Veltri MA, Fackler JC (2005) Preventing adverse events in the pediatric intensive care unit: prospectively targeting factors that lead to intravenous potassium chloride order errors. Pediatr Crit Care Med 6:25–32
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Knudson, J.D., Lowry, A.W., Price, J.F. et al. Response to Intravenous Potassium Chloride Supplementation in Pediatric Cardiac Intensive Care Patients. Pediatr Cardiol 34, 887–892 (2013). https://doi.org/10.1007/s00246-012-0565-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00246-012-0565-4